| 3001 | aparc-DKTatlas rh area fusiform | GCST90003270 | 1.00 |
| 3002 | Free cholesterol in large HDL | GCST90497786 | 1.00 |
| 3003 | Administrative and legal statuses - NHS patient: not formally detained | Summary Administration | UKBB00000012 | 1.00 |
| 3004 | Cholesteryl ester levels in large LDL | GCST90092858 | 1.00 |
| 3005 | Other/unspecified dorsalgia | FING00001124 | 1.00 |
| 3006 | IDP dMRI TBSS L3 Middle cerebellar peduncle | GCST90004171 | 1.00 |
| 3007 | Left-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302737 | 1.00 |
| 3008 | FOXO3/MAP3K5 ratio | GCST90314880 | 1.00 |
| 3009 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90025434 | 1.00 |
| 3010 | Docosahexaenoic acid to total fatty acids percentage | GCST90502285 | 0.99 |
| 3011 | IDP dMRI ProbtrackX ISOVF fmi | GCST90004536 | 0.99 |
| 3012 | Treatment speciality of consultant (recoded) - Dermatology | Summary Administration | UKBB00000830 | 0.99 |
| 3013 | Free cholesterol levels in very large HDL | GCST90093008 | 0.99 |
| 3014 | Venous thromboembolism | GCST90399744 | 0.99 |
| 3015 | Aniseed liking | GCST90094689 | 0.99 |
| 3016 | IDP dMRI ProbtrackX ICVF ilf l | GCST90004389 | 0.99 |
| 3017 | LTBP2/MYOC ratio | GCST90315337 | 0.99 |
| 3018 | FGF23 levels | GCST90012022 | 0.99 |
| 3019 | GCG levels | GCST90469316 | 0.99 |
| 3020 | ARTN levels | GCST90468372 | 0.99 |
| 3021 | wg rh intensity-contrast parsopercularis | GCST90003844 | 0.99 |
| 3022 | ROBO2/SFTPD ratio | GCST90315785 | 0.99 |
| 3023 | Diabetes type 2 with peripheral circulatory (PheCode 250.25) | GCST90475678 | 0.99 |
| 3024 | Left-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302706 | 0.98 |
| 3025 | Chronic ischaemic heart disease | Ischaemic heart diseases | UKBB00000137 | 0.98 |
| 3026 | aseg lh intensity Caudate | GCST90003769 | 0.98 |
| 3027 | DTI TBSS L1 Posterior limb of internal capsule R | GCST90384446 | 0.98 |
| 3028 | CD69/PLXNA4 ratio | GCST90313880 | 0.98 |
| 3029 | Insulin fold change during an oral glucose tolerance test (adjusted for BMI) | GCST90267567 | 0.98 |
| 3030 | IDP T1 FAST ROIs R putamen | GCST90002552 | 0.98 |
| 3031 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 0.98 |
| 3032 | Operative procedures - Carpal tunnel release | Summary Operations | UKBB00000574 | 0.98 |
| 3033 | DAB2/FKBP1B ratio | GCST90314362 | 0.98 |
| 3034 | BSG/PCDH1 ratio | GCST90313535 | 0.98 |
| 3035 | Lysoalkylphosphatidylcholine (O-24:2) levels | GCST90025438 | 0.98 |
| 3036 | Chronic dermatitis due to solar radiation (PheCode 938.2) | GCST90476288 | 0.97 |
| 3037 | COL18A1/RARRES2 ratio | GCST90314169 | 0.97 |
| 3038 | Subjective well-being | GCST90104897 | 0.97 |
| 3039 | CA2/HMBS ratio | GCST90313579 | 0.97 |
| 3040 | DTI TBSS FA Superior longitudinal fasciculus R | GCST90384420 | 0.97 |
| 3041 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202 | ECGU000202 | 0.97 |
| 3042 | Brugada syndrome | GCST90086158 | 0.97 |
| 3043 | IDP dMRI TBSS L2 Posterior corona radiata R | GCST90004149 | 0.97 |
| 3044 | IDP dMRI TBSS FA Posterior thalamic radiation L | GCST90003906 | 0.97 |
| 3045 | 1-stearoyl-2-oleoyl-GPS (18:0/18:1) levels | GCST90199652 | 0.97 |
| 3046 | rfMRI amplitudes (ICA100 node 12) | GCST90004600 | 0.97 |
| 3047 | Total lipid levels in IDL | GCST90132633 | 0.96 |
| 3048 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 0.96 |
| 3049 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 88) | GCST90320907 | 0.96 |
| 3050 | PRR4 levels | GCST90470338 | 0.96 |
| 3051 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359 | ECGU000359 | 0.96 |
| 3052 | Peripheral vascular disease | GCST90475219 | 0.96 |
| 3053 | PDGFB/VEGFC ratio | GCST90315635 | 0.96 |
| 3054 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 0.96 |
| 3055 | Anemia of chronic disease (PheCode 285.2) | GCST90475790 | 0.96 |
| 3056 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T218 | ECGA000218 | 0.96 |
| 3057 | Membranous nephropathy | GCST010006 | 0.95 |
| 3058 | RILPL2 levels | GCST90470470 | 0.95 |
| 3059 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199 | ECGU000199 | 0.95 |
| 3060 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500359 | 0.95 |
| 3061 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 0.95 |
| 3062 | Parkinson's disease | FING00001150 | 0.95 |
| 3063 | Biological Grandparent (paternal): Coronary Artery / Coronary Heart Disease | GCST90475548 | 0.95 |
| 3064 | DTI autoptx L3 ptr l tract | GCST90385212 | 0.95 |
| 3065 | DCXR/GSTA1 ratio | GCST90314437 | 0.95 |
| 3066 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320681 | 0.95 |
| 3067 | Other peripheral nerve disorders | neurological | UKBB00000618 | 0.95 |
| 3068 | Repeated disturbing thoughts of stressful experience in past month | Traumatic events | UKBB00000750 | 0.95 |
| 3069 | CD84/DAG1 ratio | GCST90313910 | 0.95 |
| 3070 | Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organs | UKBB00000425 | 0.94 |
| 3071 | Tobacco use | FING00001365 | 0.94 |
| 3072 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337 | ECGU000337 | 0.94 |
| 3073 | IDP dMRI TBSS MD External capsule R | GCST90004059 | 0.94 |
| 3074 | Loud music exposure frequency | Hearing | UKBB00000410 | 0.94 |
| 3075 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78 | ECGU000078 | 0.93 |
| 3076 | Cholesterol levels in very small VLDL | GCST90093028 | 0.93 |
| 3077 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 0.93 |
| 3078 | PALM2 levels | GCST90470152 | 0.93 |
| 3079 | ENTPD5 levels | GCST90469121 | 0.93 |
| 3080 | AK1/PEBP1 ratio | GCST90313225 | 0.93 |
| 3081 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 100) | GCST90320919 | 0.93 |
| 3082 | C3 levels | GCST90281041 | 0.93 |
| 3083 | rfMRI amplitudes (ICA100 node 2) | GCST90004590 | 0.93 |
| 3084 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 0.93 |
| 3085 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000181 | 0.93 |
| 3086 | PLXNA4/SPRY2 ratio | GCST90315687 | 0.93 |
| 3087 | Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2) | GCST90476004 | 0.92 |
| 3088 | Disorders of lacrimal system | FING00000441 | 0.92 |
| 3089 | IDP dMRI ProbtrackX L1 unc l | GCST90004271 | 0.92 |
| 3090 | Total lipids in large LDL (UKB data field 23531) | GCST90269628 | 0.92 |
| 3091 | Average diameter for HDL particles | GCST90132702 | 0.92 |
| 3092 | L1CAM/SEZ6L ratio | GCST90315266 | 0.92 |
| 3093 | IDP dMRI TBSS OD External capsule L | GCST90004435 | 0.92 |
| 3094 | Multi-trait sex score | GCST90270116 | 0.92 |
| 3095 | Concentration of IDL particles (UKB data field 23523) | GCST90269620 | 0.92 |
| 3096 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T276 | ECGU000276 | 0.92 |
| 3097 | CDKN1A/YES1 ratio | GCST90313980 | 0.92 |
| 3098 | Phospholipid levels in very large HDL | GCST90093012 | 0.92 |
| 3099 | RNF43 levels | GCST90422482 | 0.92 |
| 3100 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T470 | ECGA000470 | 0.92 |
| 3101 | Disorders of ocular muscles, binocular movement, accommodation and refraction | FING00000446 | 0.92 |
| 3102 | DTI autoptx L2 slf r tract | GCST90385188 | 0.92 |
| 3103 | Abnormal heart sounds (PheCode 396) | GCST90475916 | 0.91 |
| 3104 | Pain in limb (PheCode 773) | GCST90476270 | 0.91 |
| 3105 | Total cholesterol levels | GCST90092985 | 0.91 |
| 3106 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T131 | ECGU000131 | 0.91 |
| 3107 | BAG6/WASF1 ratio | GCST90313452 | 0.91 |
| 3108 | N6-acetyllysine levels in chronic kidney disease | GCST90257531 | 0.91 |
| 3109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T80 | ECGA000080 | 0.91 |
| 3110 | GLRX2 levels | GCST90241278 | 0.91 |
| 3111 | IDP dMRI TBSS L3 Posterior thalamic radiation L | GCST90004200 | 0.91 |
| 3112 | BA-exvivo lh volume BA4p | GCST90002840 | 0.91 |
| 3113 | Defects in the complement system | FING00000383 | 0.91 |
| 3114 | Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | GCST90200001 | 0.91 |
| 3115 | T1 FreeSurfer a2009s lh G precentral volume | GCST90384844 | 0.91 |
| 3116 | Plasma 1-methylurate levels in chronic kidney disease | GCST90264240 | 0.91 |
| 3117 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498007 | 0.91 |
| 3118 | Mean corpuscular hemoglobin concentration | GCST90018745 | 0.91 |
| 3119 | QC T1 inverse SNR | GCST90006348 | 0.90 |
| 3120 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431 | ECGU000431 | 0.90 |
| 3121 | rfMRI connectivity (ICA100 edge 1066) | GCST90005919 | 0.90 |
| 3122 | CCL25 levels | GCST90468577 | 0.90 |
| 3123 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 0.90 |
| 3124 | Benign neoplasm of eye (PheCode 224) | GCST90475626 | 0.90 |
| 3125 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T491 | ECGA000491 | 0.90 |
| 3126 | Hand grip strength left (UKB data field 46) | GCST90468168 | 0.90 |
| 3127 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 0.90 |
| 3128 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78 | ECGA000078 | 0.90 |
| 3129 | aseg lh volume CerebralWhiteMatter | GCST90002615 | 0.90 |
| 3130 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T350 | ECGU000350 | 0.90 |
| 3131 | ENO2/SULT1A1 ratio | GCST90314669 | 0.90 |
| 3132 | IDP dMRI ProbtrackX MD ilf r | GCST90004234 | 0.90 |
| 3133 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 0.89 |
| 3134 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 0.89 |
| 3135 | Monounsaturated fatty acid levels | GCST90499090 | 0.89 |
| 3136 | Hydrocephalus | FING00000628 | 0.89 |
| 3137 | GYS1/TIA1 ratio | GCST90315004 | 0.89 |
| 3138 | Metabolonic lactone sulfate levels | GCST90200257 | 0.89 |
| 3139 | Chalazion | FING00000267 | 0.88 |
| 3140 | aparc-a2009s lh area G-parietal-sup | GCST90003323 | 0.88 |
| 3141 | MFAP4 levels | GCST90469898 | 0.88 |
| 3142 | Retinal thickness (functional principal component 2) | GCST90455722 | 0.88 |
| 3143 | LTBP3 levels | GCST90469815 | 0.88 |
| 3144 | Left ventricular end-diastolic volume | GCST90268124 | 0.88 |
| 3145 | DTI TBSS L2 Retrolenticular part of internal capsule R | GCST90384496 | 0.88 |
| 3146 | Total free cholesterol levels (UKB data field 23419) | GCST90269516 | 0.88 |
| 3147 | Cholesteryl esters in medium VLDL (UKB data field 23506) | GCST90269603 | 0.88 |
| 3148 | Childhood maltreatment | GCST90551832 | 0.88 |
| 3149 | MPIG6B/PLXNA4 ratio | GCST90315483 | 0.88 |
| 3150 | F9/FURIN ratio | GCST90314747 | 0.88 |
| 3151 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466 | ECGA000466 | 0.88 |
| 3152 | Phospholipids to total lipids ratio in large VLDL | GCST90092877 | 0.88 |
| 3153 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 0.88 |
| 3154 | IDP dMRI ProbtrackX ICVF ar r | GCST90004376 | 0.88 |
| 3155 | CNTN5 levels | GCST90468807 | 0.87 |
| 3156 | GP1BB levels | GCST90469381 | 0.87 |
| 3157 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T343 | ECGU000343 | 0.87 |
| 3158 | ANGPTL1 levels | GCST90468302 | 0.87 |
| 3159 | ERP29 levels | GCST90088843 | 0.87 |
| 3160 | Free cholesterol in medium VLDL | GCST90498960 | 0.87 |
| 3161 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499564 | 0.87 |
| 3162 | Total free cholesterol levels | GCST90092988 | 0.87 |
| 3163 | Breakthrough COVID-19 susceptibility after at least one dose of a COVID-19 vaccine | GCST90448695 | 0.87 |
| 3164 | CD84/CDKN1A ratio | GCST90313909 | 0.87 |
| 3165 | SVEP1 levels | GCST90242928 | 0.87 |
| 3166 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 0.87 |
| 3167 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T348 | ECGU000348 | 0.86 |
| 3168 | Acne (PheCode 706.1) | GCST90476211 | 0.86 |
| 3169 | aparc-DKTatlas lh volume lateraloccipital | GCST90002871 | 0.86 |
| 3170 | Phospholipids in very large VLDL | GCST90500647 | 0.86 |
| 3171 | Other chronic ischemic heart disease, unspecified (PheCode 411.8) | GCST90475938 | 0.86 |
| 3172 | IDP dMRI ProbtrackX L3 ptr l | GCST90004319 | 0.86 |
| 3173 | Nonischemic cardiomyopathy | FING00000883 | 0.86 |
| 3174 | CCL5/CXCL3 ratio | GCST90313700 | 0.86 |
| 3175 | Physical activity (Relative amplitude) | GCST90061432 | 0.86 |
| 3176 | IDP T1 FAST ROIs R lingual gyrus | GCST90002522 | 0.86 |
| 3177 | Triacylglycerol (54:0) [NL-18:0] levels | GCST90025173 | 0.86 |
| 3178 | CPA2 levels | GCST90468837 | 0.86 |
| 3179 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 0.86 |
| 3180 | Fasting blood glucose | GCST005186 | 0.86 |
| 3181 | Heterophoria | FING00000620 | 0.86 |
| 3182 | diastolic blood pressure (DBP, maximum, inv-normal transformed) | GCST90475252 | 0.86 |
| 3183 | Unspecified acute lower respiratory infection | FING00001398 | 0.86 |
| 3184 | Fasting insulin | GCST90002238 | 0.85 |
| 3185 | Total Sphingomyelin levels | GCST90025842 | 0.85 |
| 3186 | ATRN levels | GCST90468400 | 0.85 |
| 3187 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499335 | 0.85 |
| 3188 | DLL1/TGFBR2 ratio | GCST90314499 | 0.85 |
| 3189 | Total lipids in large LDL | GCST90498021 | 0.85 |
| 3190 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497929 | 0.85 |
| 3191 | CALCOCO1/PFKFB2 ratio | GCST90313608 | 0.85 |
| 3192 | wg rh intensity-contrast supramarginal | GCST90003857 | 0.85 |
| 3193 | Prescriptions - thiazide diuretic|diuretic | UKBB00000704 | 0.85 |
| 3194 | Memory loss or impairment | GCST90475544 | 0.85 |
| 3195 | IDP T1 FAST ROIs L ventral striatum | GCST90002559 | 0.84 |
| 3196 | Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302677 | 0.84 |
| 3197 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98 | ECGA000098 | 0.84 |
| 3198 | Myocardial fractal dimension (slice 6) | GCST90000292 | 0.84 |
| 3199 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000443 | 0.84 |
| 3200 | ENPP2/TNFRSF11B ratio | GCST90314672 | 0.84 |
| 3201 | Free Cholesterol in LDL | GCST90498388 | 0.83 |
| 3202 | BA-exvivo rh area entorhinal | GCST90003234 | 0.83 |
| 3203 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489 | ECGA000489 | 0.83 |
| 3204 | Cerebrospinal fluid beta-hydroxyisovaleroylcarnitine levels | GCST90318013 | 0.83 |
| 3205 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 0.83 |
| 3206 | Non-cancer illness code, self-reported - high cholesterol | Medical conditions | UKBB00000516 | 0.83 |
| 3207 | NMT1 levels | GCST90470059 | 0.83 |
| 3208 | DTI TBSS L2 Uncinate fasciculus R | GCST90384520 | 0.83 |
| 3209 | Free cholesterol levels in IDL | GCST90132676 | 0.83 |
| 3210 | Cholesteryl esters in very small VLDL (UKB data field 23520) | GCST90269617 | 0.83 |
| 3211 | Systolic blood pressure (standard GWA) | GCST90267304 | 0.83 |
| 3212 | aparc-a2009s lh area S-precentral-sup-part | GCST90003365 | 0.82 |
| 3213 | Severe hearing loss or partial deafness in one or both ears | GCST90475385 | 0.82 |
| 3214 | NTPROBNP levels | GCST90470096 | 0.82 |
| 3215 | N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels | GCST90200115 | 0.82 |
| 3216 | Pulse wave Arterial Stiffness index | Arterial stiffness | UKBB00000724 | 0.82 |
| 3217 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 0.82 |
| 3218 | aparc-a2009s lh area S-central | GCST90003341 | 0.82 |
| 3219 | Alkenylphosphatidylcholine (P-36:3) levels | GCST90024954 | 0.82 |
| 3220 | Androsterone sulfate levels | GCST90200674 | 0.82 |
| 3221 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 0.82 |
| 3222 | MITD1/RHOC ratio | GCST90315453 | 0.82 |
| 3223 | Type 1 diabetes (PheCode 250.1) | GCST90475661 | 0.81 |
| 3224 | Cholesteryl esters in large LDL (UKB data field 23534) | GCST90269631 | 0.81 |
| 3225 | Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500333 | 0.81 |
| 3226 | ICD10 E28.2: Polycystic ovarian syndrome | GCST90454205 | 0.81 |
| 3227 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471 | ECGA000471 | 0.81 |
| 3228 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500943 | 0.81 |
| 3229 | NRAC levels | GCST90617991 | 0.81 |
| 3230 | Freckles | GCST006091 | 0.81 |
| 3231 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468 | ECGA000468 | 0.81 |
| 3232 | TBCB/TBCC ratio | GCST90315909 | 0.81 |
| 3233 | 10-undecenoate (11:1n1) levels | GCST90243596 | 0.81 |
| 3234 | Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers) | FING00000846 | 0.81 |
| 3235 | Dried fruit liking | GCST90094756 | 0.81 |
| 3236 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 0.81 |
| 3237 | Migraine | FING00000818 | 0.81 |
| 3238 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T349 | ECGU000349 | 0.80 |
| 3239 | Solitary pulmonary nodule (PheCode 514.2) | GCST90476044 | 0.80 |
| 3240 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494 | ECGA000494 | 0.80 |
| 3241 | IDP dMRI ProbtrackX L1 fmi | GCST90004257 | 0.80 |
| 3242 | NT5C3A/PRDX5 ratio | GCST90315567 | 0.80 |
| 3243 | Synonym | Fluid intelligence / reasoning | UKBB00000802 | 0.80 |
| 3244 | Benign mammary dysplasia | FING00000151 | 0.80 |
| 3245 | Degree of unsaturation | GCST90502737 | 0.80 |
| 3246 | CA11 levels | GCST90468506 | 0.80 |
| 3247 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T192 | ECGA000192 | 0.80 |
| 3248 | Pulse wave peak to peak time | Arterial stiffness | UKBB00000725 | 0.80 |
| 3249 | 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels | GCST90200685 | 0.80 |
| 3250 | HippSubfield rh volume GC-ML-DG-body | GCST90002703 | 0.79 |
| 3251 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463 | ECGA000463 | 0.79 |
| 3252 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334 | ECGU000334 | 0.79 |
| 3253 | DOK2/LACTB2 ratio | GCST90314532 | 0.79 |
| 3254 | RBP2 levels | GCST90470438 | 0.79 |
| 3255 | Chronic osteomyelitis (PheCode 710.12) | GCST90476223 | 0.79 |
| 3256 | Other disorders of skin and subcutaneous tissue | FING00001035 | 0.79 |
| 3257 | CTSD/PRCP ratio | GCST90314312 | 0.79 |
| 3258 | Osteoarthritis | GCST90134279 | 0.79 |
| 3259 | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | GCST90302701 | 0.79 |
| 3260 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 0.79 |
| 3261 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 0.79 |
| 3262 | AGRN/BTN2A1 ratio | GCST90313199 | 0.78 |
| 3263 | Total Lipids in LDL | GCST90498405 | 0.78 |
| 3264 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 0.78 |
| 3265 | Fracture of upper limb (PheCode 803) | GCST90476279 | 0.78 |
| 3266 | Free cholesterol to total lipids ratio in large HDL | GCST90092849 | 0.78 |
| 3267 | DECR1/METAP1D ratio | GCST90314448 | 0.78 |
| 3268 | ADAM15 levels | GCST90468217 | 0.78 |
| 3269 | T1 FreeSurfer a2009s lh S postcentral volume | GCST90384882 | 0.78 |
| 3270 | Cholesteryl ester levels in medium VLDL | GCST90092918 | 0.78 |
| 3271 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 0.78 |
| 3272 | Volume of right paralaminar nucleus | GCST90474928 | 0.78 |
| 3273 | F9 levels | GCST90469172 | 0.78 |
| 3274 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.77 |
| 3275 | CHCHD6 levels | GCST90468739 | 0.77 |
| 3276 | Corneal edema (PheCode 364.2) | GCST90475862 | 0.77 |
| 3277 | Microalbumin in urine | Urine assays | UKBB00000467 | 0.77 |
| 3278 | CDKN1A/TXLNA ratio | GCST90313979 | 0.77 |
| 3279 | METAP2/USP8 ratio | GCST90315434 | 0.77 |
| 3280 | Diacylglycerol_44:7_[M+H-H2O]1+ levels | GCST90060240 | 0.77 |
| 3281 | aparc-a2009s rh area S-postcentral | GCST90003437 | 0.77 |
| 3282 | HippSubfield lh volume subiculum-body | GCST90002669 | 0.77 |
| 3283 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T351 | ECGU000351 | 0.77 |
| 3284 | Chronic ulcer of leg or foot (PheCode 707.2) | GCST90476218 | 0.77 |
| 3285 | Average diameter for LDL particles | GCST90498458 | 0.77 |
| 3286 | PLA2G4A/SNX9 ratio | GCST90315670 | 0.77 |
| 3287 | Diacylglycerol_42:7_[M+H-H2O]1+ levels | GCST90060226 | 0.77 |
| 3288 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T219 | ECGA000219 | 0.77 |
| 3289 | DTI TBSS MD Superior longitudinal fasciculus L | GCST90384613 | 0.77 |
| 3290 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203 | ECGU000203 | 0.76 |
| 3291 | Total cholesterol minus HDL-C levels | GCST90092930 | 0.76 |
| 3292 | AmygNuclei rh volume Paralaminar-nucleus | GCST90002666 | 0.76 |
| 3293 | ABHD14B/SCRN1 ratio | GCST90313145 | 0.76 |
| 3294 | Cholesterol to total lipids in large HDL percentage (UKB data field 23635) | GCST90269732 | 0.76 |
| 3295 | Pain type(s) experienced in last month - Hip pain | Pain | UKBB00000628 | 0.76 |
| 3296 | Mononeuropathies of upper limb | Nerve, nerve root and plexus disorders | UKBB00000481 | 0.76 |
| 3297 | Left-hemisphere default mode network to accumbens white-matter structural connectivity | GCST90302773 | 0.76 |
| 3298 | Phospholipids in large LDL (UKB data field 23532) | GCST90269629 | 0.76 |
| 3299 | AZU1 levels | GCST90468408 | 0.76 |
| 3300 | Arabitol/xylitol levels | GCST90200011 | 0.76 |
| 3301 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500949 | 0.76 |
| 3302 | End stage renal disease (PheCode 585.32) | GCST90476126 | 0.76 |
| 3303 | Obstructed labour due to maternal pelvic abnormality | FING00000899 | 0.76 |
| 3304 | ANXA3/ANXA4 ratio | GCST90313278 | 0.76 |
| 3305 | Unspecified/other endometriosis | FING00001404 | 0.76 |
| 3306 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 0.75 |
| 3307 | Clinical LDL cholesterol levels (UKB data field 23404) | GCST90269501 | 0.75 |
| 3308 | Leisure/social activities - Adult education class | Social support | UKBB00000398 | 0.75 |
| 3309 | ADGRG2/SDC1 ratio | GCST90313187 | 0.75 |
| 3310 | IDP dMRI ProbtrackX FA ifo l | GCST90003937 | 0.75 |
| 3311 | Volume of right cortico-amygdaloid transition area | GCST90474911 | 0.75 |
| 3312 | IPCEF1/SERPINE1 ratio | GCST90315184 | 0.75 |
| 3313 | Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302649 | 0.75 |
| 3314 | IL18R1 levels | GCST90241607 | 0.75 |
| 3315 | IDP dMRI ProbtrackX OD ilf r | GCST90004465 | 0.75 |
| 3316 | Gamma glutamyl transpeptidase | GCST90018734 | 0.75 |
| 3317 | PLIN3/VSIR ratio | GCST90315679 | 0.75 |
| 3318 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 0.75 |
| 3319 | CTSH levels | GCST90088501 | 0.75 |
| 3320 | aparc-a2009s rh area G+S-occipital-inf | GCST90003372 | 0.74 |
| 3321 | Concentration of very small VLDL particles | GCST90500819 | 0.74 |
| 3322 | PROK2 levels | GCST90617073 | 0.74 |
| 3323 | ACYP1 levels | GCST90468214 | 0.74 |
| 3324 | Total concentration of lipoprotein particles | GCST90092990 | 0.74 |
| 3325 | Asthma with exacerbation (PheCode 495.2) | GCST90476025 | 0.74 |
| 3326 | Sleep apnea (MTAG) | GCST90267362 | 0.74 |
| 3327 | DTI TBSS L1 Body of corpus callosum | GCST90384431 | 0.74 |
| 3328 | IDP dMRI TBSS ICVF Posterior limb of internal capsule L | GCST90004346 | 0.74 |
| 3329 | IGSF3 levels | GCST90469539 | 0.74 |
| 3330 | BIRC2/CD40LG ratio | GCST90313517 | 0.74 |
| 3331 | PDGFB levels | GCST90012016 | 0.74 |
| 3332 | CXCL5/EDAR ratio | GCST90314349 | 0.74 |
| 3333 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 0.74 |
| 3334 | PODXL2/SDC1 ratio | GCST90315701 | 0.74 |
| 3335 | PON2 levels | GCST90470286 | 0.74 |
| 3336 | Average diameter for VLDL particles | GCST90093002 | 0.74 |
| 3337 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 0.73 |
| 3338 | IPCEF1/TBCC ratio | GCST90315188 | 0.73 |
| 3339 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T130 | ECGU000130 | 0.73 |
| 3340 | CXCL14 levels | GCST90468927 | 0.73 |
| 3341 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320900 | 0.73 |
| 3342 | Other septicaemia | FING00001097 | 0.73 |
| 3343 | Triglycerides to total lipids ratio in large LDL | GCST90092867 | 0.73 |
| 3344 | rfMRI amplitudes (ICA100 node 40) | GCST90004628 | 0.73 |
| 3345 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495 | ECGA000495 | 0.73 |
| 3346 | mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed) | GCST90475452 | 0.73 |
| 3347 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T479 | ECGA000479 | 0.73 |
| 3348 | Total lipid levels in HDL | GCST90092825 | 0.73 |
| 3349 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430 | ECGU000430 | 0.73 |
| 3350 | MAP4K5/TBCC ratio | GCST90315385 | 0.73 |
| 3351 | Biological Mother: High blood pressure | GCST90475490 | 0.73 |
| 3352 | Gastric ulcer | GCST90018631 | 0.73 |
| 3353 | Concentration of large LDL particles | GCST90498029 | 0.73 |
| 3354 | HSIL lesion of the vulva | FING00000626 | 0.72 |
| 3355 | IL1RAP levels | GCST90469573 | 0.72 |
| 3356 | IDP dMRI ProbtrackX ICVF ptr r | GCST90004395 | 0.72 |
| 3357 | AXIN1/MAP2K6 ratio | GCST90313413 | 0.72 |
| 3358 | CXCL16 levels | GCST90012059 | 0.72 |
| 3359 | Atrial fibrillation | GCST006414 | 0.72 |
| 3360 | Alpha-hydroxyisovalerate levels | GCST90199736 | 0.72 |
| 3361 | Urine proline levels in chronic kidney disease | GCST90265873 | 0.72 |
| 3362 | IDP dMRI TBSS L3 Posterior thalamic radiation R | GCST90004199 | 0.72 |
| 3363 | Concentration of HDL particles | GCST90092826 | 0.72 |
| 3364 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90093050 | 0.72 |
| 3365 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 0.72 |
| 3366 | Reticulocyte percentage | Blood count | UKBB00000753 | 0.72 |
| 3367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.72 |
| 3368 | Melanoma | GCST90011809 | 0.72 |
| 3369 | wg rh intensity-contrast temporalpole | GCST90003859 | 0.72 |
| 3370 | IDP dMRI TBSS ICVF Fornix | GCST90004332 | 0.71 |
| 3371 | Concentration of very large HDL particles | GCST90500436 | 0.71 |
| 3372 | Non-cancer illness code, self-reported - osteoarthritis | Medical conditions | UKBB00000521 | 0.71 |
| 3373 | Dementia | FING00000391 | 0.71 |
| 3374 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 0.71 |
| 3375 | Concentration of medium HDL particles | GCST90092899 | 0.71 |
| 3376 | MSTN levels | GCST90469953 | 0.71 |
| 3377 | Cholesterol levels in very large VLDL | GCST90093016 | 0.71 |
| 3378 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320599 | 0.71 |
| 3379 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482 | ECGA000482 | 0.71 |
| 3380 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | GCST90004369 | 0.71 |
| 3381 | Total lipids in very large HDL | GCST90500423 | 0.71 |
| 3382 | LYN/YES1 ratio | GCST90315351 | 0.70 |
| 3383 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499831 | 0.70 |
| 3384 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341 | ECGU000341 | 0.70 |
| 3385 | DTI TBSS L3 Genu of corpus callosum | GCST90384526 | 0.70 |
| 3386 | BLMH/SERPINE1 ratio | GCST90313520 | 0.70 |
| 3387 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T352 | ECGU000352 | 0.70 |
| 3388 | PMVK/PRDX5 ratio | GCST90315694 | 0.70 |
| 3389 | Triglycerides to total lipids ratio in IDL | GCST90092842 | 0.70 |
| 3390 | Phospholipid levels in HDL | GCST90092827 | 0.70 |
| 3391 | Cholesteryl esters to total lipids ratio in very small VLDL | GCST90093031 | 0.70 |
| 3392 | N-formylmethionine levels | GCST90200343 | 0.69 |
| 3393 | ABHD14B/CRADD ratio | GCST90313141 | 0.69 |
| 3394 | Handedness (confirmatory factor analysis Factor 36) | GCST90309370 | 0.69 |
| 3395 | GFRA3/LAYN ratio | GCST90314926 | 0.69 |
| 3396 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467 | ECGA000467 | 0.69 |
| 3397 | DOK2/PPP1R12A ratio | GCST90314536 | 0.69 |
| 3398 | Job involves shift work | Employment | UKBB00000385 | 0.69 |
| 3399 | Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555) | GCST90476065 | 0.69 |
| 3400 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353 | ECGU000353 | 0.69 |
| 3401 | Prescriptions - prostaglandin analog | UKBB00000697 | 0.69 |
| 3402 | T1 FreeSurfer DK rh cuneus area | GCST90385693 | 0.69 |
| 3403 | Right-hemisphere somatomotor network to caudate white-matter structural connectivity | GCST90302795 | 0.69 |
| 3404 | systolic blood pressure (SBP, maximum, inv-normal transformed) | GCST90476400 | 0.69 |
| 3405 | N-delta-acetylornithine levels | GCST90200691 | 0.68 |
| 3406 | Prescriptions - bendroflumethiazide | thiazide diuretic,diuretic | UKBB00000667 | 0.68 |
| 3407 | Hearing aid use | GCST90044774 | 0.68 |
| 3408 | MAPK13 levels | GCST90241949 | 0.68 |
| 3409 | CCN2/HBEGF ratio | GCST90313713 | 0.68 |
| 3410 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206 | ECGU000206 | 0.68 |
| 3411 | CEBPB levels | GCST90468700 | 0.68 |
| 3412 | Cancer within the respiratory system (PheCode 165) | GCST90475571 | 0.68 |
| 3413 | Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302776 | 0.67 |
| 3414 | NECTIN2/TNFRSF1A ratio | GCST90315532 | 0.67 |
| 3415 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99 | ECGA000099 | 0.67 |
| 3416 | aseg global volume CC-Central | GCST90002609 | 0.67 |
| 3417 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 0.67 |
| 3418 | Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditions | UKBB00000519 | 0.67 |
| 3419 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 0.67 |
| 3420 | IDP dMRI TBSS ICVF Posterior thalamic radiation L | GCST90004356 | 0.67 |
| 3421 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 0.67 |
| 3422 | TSC22D1 levels | GCST90470973 | 0.67 |
| 3423 | IDP dMRI ProbtrackX FA atr r | GCST90003928 | 0.67 |
| 3424 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 0.67 |
| 3425 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480 | ECGA000480 | 0.67 |
| 3426 | CES3 levels | GCST90468720 | 0.67 |
| 3427 | CXCL17/LAMP3 ratio | GCST90314340 | 0.67 |
| 3428 | Coronary artery calcification | GCST90503074 | 0.67 |
| 3429 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T347 | ECGU000347 | 0.67 |
| 3430 | T1 CAT GM unnormalised volume | GCST90383982 | 0.67 |
| 3431 | Bursitis (PheCode 726.3) | GCST90476240 | 0.67 |
| 3432 | MCAM/NCAM1 ratio | GCST90315408 | 0.67 |
| 3433 | AXIN1/GOPC ratio | GCST90313407 | 0.66 |
| 3434 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439 | ECGU000439 | 0.66 |
| 3435 | Left ventricular end diastolic mass | GCST90268123 | 0.66 |
| 3436 | ALDH1A1/SORD ratio | GCST90313248 | 0.66 |
| 3437 | Free cholesterol levels in very large VLDL | GCST90093020 | 0.66 |
| 3438 | CA3 levels | GCST90468512 | 0.66 |
| 3439 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50) | GCST90320613 | 0.66 |
| 3440 | Pre-existing hypertension complicating pregnancy, childbirth and the puerperium | FING00001203 | 0.66 |
| 3441 | Glycine levels | GCST007638 | 0.66 |
| 3442 | Emotional neglect | GCST90551846 | 0.66 |
| 3443 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 0.66 |
| 3444 | aparc-Desikan lh volume lateraloccipital | GCST90002778 | 0.66 |
| 3445 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487 | ECGA000487 | 0.66 |
| 3446 | Average diameter for HDL particles | GCST90092828 | 0.66 |
| 3447 | CTSB levels | GCST90468908 | 0.66 |
| 3448 | IMPA1/TBCC ratio | GCST90315175 | 0.66 |
| 3449 | IDP dMRI TBSS L1 Cingulum hippocampus R | GCST90004111 | 0.66 |
| 3450 | EFEMP1/IL18BP ratio | GCST90314596 | 0.66 |
| 3451 | Atrial fibrillation and flutter | circulatory system | UKBB00000055 | 0.65 |
| 3452 | IDP dMRI TBSS FA Middle cerebellar peduncle | GCST90003877 | 0.65 |
| 3453 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T478 | ECGA000478 | 0.65 |
| 3454 | Non-oily fish consumption | GCST90132994 | 0.65 |
| 3455 | High cholesterol | GCST90468134 | 0.65 |
| 3456 | Microvirga abundance in stool | GCST90032479 | 0.65 |
| 3457 | Osteoporosis | GCST90086122 | 0.65 |
| 3458 | Cholesteryl Esters in Small VLDL | GCST90499786 | 0.65 |
| 3459 | Spondylopathies (FG) | FING00001326 | 0.65 |
| 3460 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28 | ECGU000028 | 0.65 |
| 3461 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 0.65 |
| 3462 | Cerebrospinal fluid methylmalonate (MMA) levels | GCST90318243 | 0.65 |
| 3463 | Right-hemisphere control network to thalamus white-matter structural connectivity | GCST90302836 | 0.65 |
| 3464 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 0.65 |
| 3465 | METAP1D/VASH1 ratio | GCST90315429 | 0.65 |
| 3466 | KLF4 levels | GCST90469694 | 0.65 |
| 3467 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 0.65 |
| 3468 | BACH1/CD2AP ratio | GCST90313435 | 0.65 |
| 3469 | Triglycerides in medium VLDL | GCST90499064 | 0.64 |
| 3470 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 0.64 |
| 3471 | IRAG2/TBC1D23 ratio | GCST90315191 | 0.64 |
| 3472 | Ratio of polyunsaturated fatty acids to monounsaturated fatty acids | GCST90092940 | 0.64 |
| 3473 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 0.64 |
| 3474 | Atrial fibrillation and flutter | Other forms of heart disease | UKBB00000056 | 0.64 |
| 3475 | COL6A3/TAFA5 ratio | GCST90314180 | 0.64 |
| 3476 | aseg global intensity WM-hypointensities | GCST90003756 | 0.64 |
| 3477 | Takes medication for asthma? | GCST90475260 | 0.64 |
| 3478 | PPM1F levels | GCST90470297 | 0.64 |
| 3479 | Cholelithiasis | Disorders of gallbladder, biliary tract and pancreas | UKBB00000132 | 0.64 |
| 3480 | Cirrhosis | GCST90018606 | 0.64 |
| 3481 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T472 | ECGA000472 | 0.64 |
| 3482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T75 | ECGA000075 | 0.64 |
| 3483 | ENG levels | GCST90469108 | 0.64 |
| 3484 | Disorders of plasma protein metabolism (PheCode 270.3) | GCST90475709 | 0.64 |
| 3485 | NOS3 levels | GCST90470064 | 0.64 |
| 3486 | Amyotrophic lateral sclerosis | GCST90027164 | 0.64 |
| 3487 | LDL cholesterol levels (UKB data field 23405) | GCST90269502 | 0.63 |
| 3488 | MEGF9/OXT ratio | GCST90315419 | 0.63 |
| 3489 | Atherosclerosis of the extremities (PheCode 440.2) | GCST90475990 | 0.63 |
| 3490 | MUC2 levels | GCST90469965 | 0.63 |
| 3491 | APOA1 levels | GCST90092808 | 0.63 |
| 3492 | wg rh intensity-contrast rostralanteriorcingulate | GCST90003852 | 0.63 |
| 3493 | CRADD/MAP4K5 ratio | GCST90314240 | 0.63 |
| 3494 | ICD10 N86: Erosion and ectropion of cervix uteri | GCST90454217 | 0.63 |
| 3495 | aparc-pial rh area parstriangularis | GCST90003193 | 0.63 |
| 3496 | ST6GALNAC2 levels | GCST90240251 | 0.63 |
| 3497 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 0.63 |
| 3498 | wg rh intensity-contrast precentral | GCST90003850 | 0.63 |
| 3499 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 0.63 |
| 3500 | PFKM levels | GCST90618802 | 0.63 |
| 3501 | POMC levels | GCST90470284 | 0.63 |
| 3502 | Migraine | GCST90468142 | 0.63 |
| 3503 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 0.63 |
| 3504 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499690 | 0.62 |
| 3505 | PSCA levels | GCST90470352 | 0.62 |
| 3506 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 0.62 |
| 3507 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498058 | 0.62 |
| 3508 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193 | ECGA000193 | 0.62 |
| 3509 | Cholesteryl Esters in Large HDL | GCST90497753 | 0.62 |
| 3510 | BCL2 levels | GCST90468433 | 0.62 |
| 3511 | Anterior diffusion tensor imaging along the perivascular space index | GCST90455543 | 0.62 |
| 3512 | Left-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302767 | 0.62 |
| 3513 | Right ventricular stroke volume | GCST90134590 | 0.62 |
| 3514 | Sciatica+with lumbago | FING00001279 | 0.62 |
| 3515 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 70) | GCST90320889 | 0.62 |
| 3516 | 4-acetamidobutanoate levels | GCST90243440 | 0.62 |
| 3517 | X-04499--3,4-dihydroxybutyrate levels | GCST90243497 | 0.62 |
| 3518 | Carnitine levels | GCST90243481 | 0.62 |
| 3519 | aparc-a2009s lh volume G-precentral | GCST90002953 | 0.62 |
| 3520 | Cervical cancer | GCST90011816 | 0.62 |
| 3521 | Panic attacks | Mental distress | UKBB00000634 | 0.61 |
| 3522 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346 | ECGU000346 | 0.61 |
| 3523 | COL3A1 levels | GCST90468817 | 0.61 |
| 3524 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238 | ECGA000238 | 0.61 |
| 3525 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500397 | 0.61 |
| 3526 | AHNAK levels | GCST90468261 | 0.61 |
| 3527 | Free cholesterol levels in large VLDL | GCST90092872 | 0.61 |
| 3528 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T237 | ECGU000237 | 0.61 |
| 3529 | SEMA3F levels | GCST90470570 | 0.61 |
| 3530 | Free Cholesterol in LDL | GCST90498386 | 0.61 |
| 3531 | Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132931 | 0.61 |
| 3532 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498783 | 0.61 |
| 3533 | Isolated hypothyroxinemia in pregnancy | GCST90435198 | 0.60 |
| 3534 | Urine dimethylglycine levels in chronic kidney disease | GCST90265045 | 0.60 |
| 3535 | CD164 levels | GCST90468602 | 0.60 |
| 3536 | SNAP25 levels | GCST90470691 | 0.60 |
| 3537 | Left ventricular end systole inferoseptal wall thickness | GCST90278508 | 0.60 |
| 3538 | Total cholesterol minus HDL-C levels (UKB data field 23401) | GCST90269498 | 0.60 |
| 3539 | Treatment/medication code - bendroflumethiazide | Medications | UKBB00000843 | 0.60 |
| 3540 | Idiopathic pulmonary fibrosis | GCST90399720 | 0.60 |
| 3541 | Keratoconus | FING00000709 | 0.60 |
| 3542 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72 | ECGA000072 | 0.60 |
| 3543 | HippSubfield rh volume CA3-body | GCST90002702 | 0.60 |
| 3544 | MMP8 levels | GCST90469922 | 0.60 |
| 3545 | DNA methylation GrimAge acceleration | GCST90014288 | 0.60 |
| 3546 | Cholesteryl Esters in LDL | GCST90498363 | 0.60 |
| 3547 | IDP dMRI ProbtrackX L2 ar l | GCST90004273 | 0.60 |
| 3548 | IDP dMRI TBSS L2 Middle cerebellar peduncle | GCST90004123 | 0.59 |
| 3549 | CA2/CA3 ratio | GCST90313576 | 0.59 |
| 3550 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340 | ECGU000340 | 0.59 |
| 3551 | Urine betaine levels in chronic kidney disease | GCST90264859 | 0.59 |
| 3552 | Follicular lymphoma, hilmo (controls excluding all cancers) | FING00000548 | 0.59 |
| 3553 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T194 | ECGA000194 | 0.59 |
| 3554 | Cholesterol in Large VLDL | GCST90498123 | 0.59 |
| 3555 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 0.59 |
| 3556 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R | GCST90004365 | 0.59 |
| 3557 | CKMT1A or CKMT1B levels | GCST90468760 | 0.59 |
| 3558 | Plasma argininate* levels in chronic kidney disease | GCST90264826 | 0.59 |
| 3559 | NFATC1/TJAP1 ratio | GCST90315540 | 0.59 |
| 3560 | Other follicular disorders | FING00001050 | 0.59 |
| 3561 | Free cholesterol in large VLDL | GCST90498181 | 0.59 |
| 3562 | Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivity | GCST90302720 | 0.59 |
| 3563 | Cholesterol in very small VLDL (UKB data field 23519) | GCST90269616 | 0.59 |
| 3564 | TF levels | GCST90470841 | 0.59 |
| 3565 | DTI autoptx L1 slf l tract | GCST90385160 | 0.59 |
| 3566 | CA1/CA2 ratio | GCST90313571 | 0.59 |
| 3567 | CNTN3/FETUB ratio | GCST90314164 | 0.59 |
| 3568 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90092943 | 0.59 |
| 3569 | Phospholipids to total lipids ratio in medium VLDL | GCST90092925 | 0.59 |
| 3570 | Sphingomyelin_34:1_[M+H]1+ levels | GCST90060239 | 0.59 |
| 3571 | T1 FreeSurfer BA lh V2 exvivo thickness | GCST90385529 | 0.58 |
| 3572 | Phosphatidylcholine (34:5) levels | GCST90024286 | 0.58 |
| 3573 | Benign neoplasm of eye, uveal (PheCode 224.1) | GCST90475629 | 0.58 |
| 3574 | IL13RA1 levels | GCST90469552 | 0.58 |
| 3575 | Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney disease | GCST90264321 | 0.58 |
| 3576 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90043977 | 0.58 |
| 3577 | CDH2 levels | GCST90468673 | 0.58 |
| 3578 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497969 | 0.58 |
| 3579 | PDLIM5 levels | GCST90470197 | 0.58 |
| 3580 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T62 | ECGA000062 | 0.58 |
| 3581 | ANPEP/NT5E ratio | GCST90313274 | 0.58 |
| 3582 | Cholesterol in Large HDL | GCST90497719 | 0.58 |
| 3583 | Triglycerides to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23583) | GCST90269680 | 0.58 |
| 3584 | Restless leg syndrome | FING00001255 | 0.58 |
| 3585 | APOB levels | GCST90497130 | 0.58 |
| 3586 | DTX3 levels | GCST90469048 | 0.58 |
| 3587 | BA-exvivo lh thickness BA4p | GCST90003518 | 0.58 |
| 3588 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475458 | 0.58 |
| 3589 | GABARAPL1 levels | GCST90469287 | 0.58 |
| 3590 | ThalamNuclei rh volume PuI | GCST90002738 | 0.57 |
| 3591 | Lung cancer | GCST90011812 | 0.57 |
| 3592 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000179 | 0.57 |
| 3593 | IDP dMRI TBSS ISOVF External capsule L | GCST90004510 | 0.57 |
| 3594 | Volume of right paralaminar nucleus | GCST90475051 | 0.57 |
| 3595 | CCS levels | GCST90468594 | 0.57 |
| 3596 | S100A14 levels | GCST90470515 | 0.57 |
| 3597 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469 | ECGA000469 | 0.57 |
| 3598 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 0.57 |
| 3599 | Sphingomyelin_34:0_[M+H]1+ levels | GCST90060241 | 0.57 |
| 3600 | CHMP1A/EREG ratio | GCST90314048 | 0.57 |
| 3601 | LDL cholesterol levels | GCST90092883 | 0.57 |
| 3602 | Plasma betaine levels in chronic kidney disease | GCST90264858 | 0.57 |
| 3603 | IDP dMRI TBSS ICVF Tapetum L | GCST90004374 | 0.57 |
| 3604 | Postinflammatory pulmonary fibrosis (PheCode 502) | GCST90476032 | 0.57 |
| 3605 | Cholesterol in Large LDL | GCST90497919 | 0.57 |
| 3606 | Cholesteryl Esters to Total Lipids in Very Large HDL percentage | GCST90500373 | 0.57 |
| 3607 | IDP dMRI TBSS L3 Inferior cerebellar peduncle R | GCST90004181 | 0.57 |
| 3608 | EDAR/IRAK4 ratio | GCST90314579 | 0.56 |
| 3609 | T1 FreeSurfer a2009s rh S temporal sup volume | GCST90385110 | 0.56 |
| 3610 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 0.56 |
| 3611 | Atrial fibrillation (MTAG) | GCST90449054 | 0.56 |
| 3612 | HGF/MMP9 ratio | GCST90315056 | 0.56 |
| 3613 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000178 | 0.56 |
| 3614 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432 | ECGU000432 | 0.56 |
| 3615 | IDP dMRI ProbtrackX L1 str l | GCST90004269 | 0.56 |
| 3616 | Acetone levels | GCST90092805 | 0.56 |
| 3617 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336 | ECGU000336 | 0.56 |
| 3618 | Concentration of medium LDL particles | GCST90498823 | 0.56 |
| 3619 | SMOC2 levels | GCST90060059 | 0.56 |
| 3620 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T40 | ECGA000040 | 0.56 |
| 3621 | PDGFA/SERPINE1 ratio | GCST90315618 | 0.56 |
| 3622 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T27 | ECGU000027 | 0.56 |
| 3623 | PDGFRB levels | GCST90470192 | 0.56 |
| 3624 | aparc-a2009s rh area G-pariet-inf-Supramar | GCST90003396 | 0.56 |
| 3625 | Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitor | UKBB00000694 | 0.56 |
| 3626 | Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitor | UKBB00000706 | 0.56 |
| 3627 | HGS levels | GCST90469450 | 0.55 |
| 3628 | MCAM levels | GCST90469870 | 0.55 |
| 3629 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T342 | ECGU000342 | 0.55 |
| 3630 | rfMRI connectivity (ICA100 edge 619) | GCST90005472 | 0.55 |
| 3631 | Cholesterol in medium VLDL (UKB data field 23505) | GCST90269602 | 0.55 |
| 3632 | aparc-Desikan lh area rostralmiddlefrontal | GCST90003099 | 0.55 |
| 3633 | 5,6-dihydrouridine levels | GCST90199767 | 0.55 |
| 3634 | LEPR levels | GCST90469756 | 0.55 |
| 3635 | Doctor diagnosed hayfever or allergic rhinitis | Medical information | UKBB00000192 | 0.55 |
| 3636 | Leg predicted mass (right) | Impedance measures | UKBB00000397 | 0.55 |
| 3637 | IDP dMRI TBSS L1 Anterior limb of internal capsule R | GCST90004091 | 0.55 |
| 3638 | DSG2 levels | GCST90427825 | 0.55 |
| 3639 | Endometriosis | FING00000497 | 0.55 |
| 3640 | CD74/IL18BP ratio | GCST90313892 | 0.55 |
| 3641 | S100A11 levels | GCST90470512 | 0.55 |
| 3642 | Primary Raynaud’s phenomenon | GCST90271714 | 0.55 |
| 3643 | Phosphatidylcholine diacyl C38:3 levels | GCST90240045 | 0.55 |
| 3644 | Cholesterol in Large VLDL | GCST90498119 | 0.55 |
| 3645 | Cholesteryl Esters in VLDL | GCST90500205 | 0.55 |
| 3646 | CHI3L1/HSPG2 ratio | GCST90314043 | 0.55 |
| 3647 | Total cholines levels (UKB data field 23436) | GCST90269533 | 0.55 |
| 3648 | Lifespan | GCST90551885 | 0.54 |
| 3649 | Cholesterol in Large LDL | GCST90497923 | 0.54 |
| 3650 | EGFLAM levels | GCST90421651 | 0.54 |
| 3651 | EFNA4/LAYN ratio | GCST90314602 | 0.54 |
| 3652 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 0.54 |
| 3653 | Leg fat-free mass (right) | Impedance measures | UKBB00000394 | 0.54 |
| 3654 | IDP dMRI TBSS L3 Sagittal stratum R | GCST90004201 | 0.54 |
| 3655 | NGRN levels | GCST90470045 | 0.54 |
| 3656 | Basal metabolic rate | Impedance measures | UKBB00000086 | 0.54 |
| 3657 | Chronic hepatitis C infection | GCST90018585 | 0.54 |
| 3658 | DRG2/SEMA4D ratio | GCST90314554 | 0.54 |
| 3659 | IDP dMRI TBSS L2 Inferior cerebellar peduncle R | GCST90004133 | 0.54 |
| 3660 | Ascending aorta diameter | GCST90091050 | 0.54 |
| 3661 | Acetate levels | GCST90092803 | 0.54 |
| 3662 | rfMRI connectivity (ICA100 edge 495) | GCST90005348 | 0.54 |
| 3663 | Urine andro steroid monosulfate C19H28O6S (1)* levels in chronic kidney disease | GCST90264796 | 0.54 |
| 3664 | Phosphatidylglycerol (34:1) levels | GCST90025061 | 0.54 |
| 3665 | aseg lh volume Pallidum | GCST90002623 | 0.54 |
| 3666 | SPON2 levels | GCST90470732 | 0.54 |
| 3667 | Benign neoplasm: Rectum, anus and anal canal | FING00000197 | 0.54 |
| 3668 | Cholesterol levels in medium VLDL | GCST90092916 | 0.54 |
| 3669 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231 | ECGU000231 | 0.54 |
| 3670 | All pneumoniae | FING00000065 | 0.53 |
| 3671 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 0.53 |
| 3672 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T473 | ECGA000473 | 0.53 |
| 3673 | Potatoes liking | GCST90094816 | 0.53 |
| 3674 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90499288 | 0.53 |
| 3675 | FLT1/TFPI2 ratio | GCST90314856 | 0.53 |
| 3676 | CNTNAP2 levels | GCST90468808 | 0.53 |
| 3677 | Uterine fibroids | GCST90468154 | 0.53 |
| 3678 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97 | ECGA000097 | 0.53 |
| 3679 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492 | ECGA000492 | 0.53 |
| 3680 | Vascular/heart problems diagnosed by doctor - None of the above | Medical conditions | UKBB00000899 | 0.53 |
| 3681 | Iridocyclitis | FING00000696 | 0.53 |
| 3682 | Nasal polyp | Other diseases of upper respiratory tract | UKBB00000493 | 0.53 |
| 3683 | 2-hydroxyisobutyrate levels | GCST90243539 | 0.53 |
| 3684 | Concentration of large LDL particles | GCST90092863 | 0.53 |
| 3685 | Low density lipoprotein cholesterol levels | GCST90239657 | 0.53 |
| 3686 | Phospholipid levels in large VLDL | GCST90092876 | 0.52 |
| 3687 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 0.52 |
| 3688 | Other diseases of the respiratory system | FING00001011 | 0.52 |
| 3689 | EREG/GYS1 ratio | GCST90314701 | 0.52 |
| 3690 | SPINT2/TNFSF13 ratio | GCST90315879 | 0.52 |
| 3691 | NSFL1C/PSMG3 ratio | GCST90315559 | 0.52 |
| 3692 | Abdominal subcutaneous adipose tissue | GCST90267347 | 0.52 |
| 3693 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502415 | 0.52 |
| 3694 | Visceral adipose tissue | GCST90267357 | 0.52 |
| 3695 | DFFA/FOXO1 ratio | GCST90314456 | 0.52 |
| 3696 | Snoring | GCST009760 | 0.52 |
| 3697 | IDP dMRI TBSS ICVF Sagittal stratum R | GCST90004357 | 0.52 |
| 3698 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424 | ECGU000424 | 0.52 |
| 3699 | Total lipid levels in LDL | GCST90092886 | 0.52 |
| 3700 | Coronary atherosclerosis (PheCode 411.4) | GCST90475936 | 0.52 |
| 3701 | O-sulfo-l-tyrosine levels | GCST90243623 | 0.52 |
| 3702 | IDP dMRI TBSS L1 Anterior limb of internal capsule L | GCST90004092 | 0.51 |
| 3703 | T1 FIRST volume L Puta | GCST90383987 | 0.51 |
| 3704 | Healthspan | GCST007406 | 0.51 |
| 3705 | Total lipid levels in chylomicrons and extremely large VLDL | GCST90093046 | 0.51 |
| 3706 | Phospholipid levels in very large VLDL | GCST90093024 | 0.51 |
| 3707 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 0.51 |
| 3708 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189 | ECGU000189 | 0.51 |
| 3709 | SLIT2 levels | GCST90470668 | 0.51 |
| 3710 | Maximum heart rate during fitness test | ECG during exercise | UKBB00000431 | 0.51 |
| 3711 | Right-hemisphere control network to putamen white-matter structural connectivity | GCST90302838 | 0.51 |
| 3712 | Olsenella C abundance in stool | GCST90032493 | 0.51 |
| 3713 | KIAA0319 levels | GCST90469676 | 0.51 |
| 3714 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69 | ECGA000069 | 0.51 |
| 3715 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 0.51 |
| 3716 | Deforming dorsopathies | FING00000385 | 0.50 |
| 3717 | MCEMP1 levels | GCST90469872 | 0.50 |
| 3718 | PLAU/PLAUR ratio | GCST90315674 | 0.50 |
| 3719 | Benign neoplasm: Colon | FING00000171 | 0.50 |
| 3720 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 0.50 |
| 3721 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90501075 | 0.50 |
| 3722 | PDCD1/TNFRSF9 ratio | GCST90315611 | 0.50 |
| 3723 | Chronic sinusitis (PheCode 475) | GCST90476020 | 0.50 |
| 3724 | IDP dMRI TBSS L3 Anterior limb of internal capsule R | GCST90004187 | 0.50 |
| 3725 | Dermatomycosis (PheCode 110.2) | GCST90475565 | 0.50 |
| 3726 | FNDC1 levels | GCST90469256 | 0.50 |
| 3727 | IDP T1 SIENAX CSF unnormalised volume | GCST90002429 | 0.50 |
| 3728 | DTI TBSS MD Splenium of corpus callosum | GCST90384576 | 0.50 |
| 3729 | ATP5IF1/FXN ratio | GCST90313386 | 0.50 |
| 3730 | Concentration of LDL particles | GCST90498418 | 0.50 |
| 3731 | TMSB10/ZBTB16 ratio | GCST90315926 | 0.50 |
| 3732 | Anorexia (incl.atypical) | FING00000093 | 0.50 |
| 3733 | IGFBP1 levels | GCST90469527 | 0.50 |
| 3734 | Right ventricular end systolic volume | GCST90268118 | 0.50 |
| 3735 | PPP1R2/TBL1X ratio | GCST90315720 | 0.50 |
| 3736 | X-12095--N1-methyl-3-pyridone-4-carboxamide levels | GCST90243701 | 0.50 |
| 3737 | Frequency of heavy DIY in last 4 weeks | Physical activity | UKBB00000263 | 0.50 |
| 3738 | aparc-a2009s rh area S-oc-middle+Lunatus | GCST90003427 | 0.49 |
| 3739 | Left-hemisphere control network to putamen white-matter structural connectivity | GCST90302754 | 0.49 |
| 3740 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 0.49 |
| 3741 | Cholesterol in Small VLDL | GCST90499750 | 0.49 |
| 3742 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48) | GCST90320611 | 0.49 |
| 3743 | GLB1 levels | GCST90469355 | 0.49 |
| 3744 | METAP2/PFKFB2 ratio | GCST90315431 | 0.49 |
| 3745 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T485 | ECGA000485 | 0.49 |
| 3746 | Arthropathies in other diseases classified elsewhere | FING00000108 | 0.49 |
| 3747 | DBI/MESD ratio | GCST90314409 | 0.49 |
| 3748 | CRELD2/NUCB2 ratio | GCST90314256 | 0.49 |
| 3749 | LDL direct | Blood biochemistry | UKBB00000386 | 0.49 |
| 3750 | Hypertrophy of breast in women and men | FING00000645 | 0.49 |
| 3751 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) levels (UKB data field 23402) | GCST90269499 | 0.49 |
| 3752 | EFNA1/PIK3IP1 ratio | GCST90314598 | 0.49 |
| 3753 | Acute alcohol intoxication, ICD10 | FING00000015 | 0.49 |
| 3754 | IFNGR2 levels | GCST90469514 | 0.49 |
| 3755 | EIF4B/IPCEF1 ratio | GCST90314622 | 0.48 |
| 3756 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 0.48 |
| 3757 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238 | ECGU000238 | 0.48 |
| 3758 | DTI autoptx L3 str l tract | GCST90385216 | 0.48 |
| 3759 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T191 | ECGA000191 | 0.48 |
| 3760 | CLEC1B/SNAP29 ratio | GCST90314103 | 0.48 |
| 3761 | Ganglion | FING00000563 | 0.48 |
| 3762 | Other specified/unspecified inflammatory spondylopathies | FING00001109 | 0.48 |
| 3763 | DTI autoptx L1 slf r tract | GCST90385161 | 0.48 |
| 3764 | ALCAM/SPINT1 ratio | GCST90313242 | 0.48 |
| 3765 | Pizza liking | GCST90094810 | 0.48 |
| 3766 | IDP T1 SIENAX CSF normalised volume | GCST90002428 | 0.48 |
| 3767 | Testosterone levels (UKB data field 30850) | GCST90468103 | 0.48 |
| 3768 | Lichen simplex chronicus and prurigo | FING00000725 | 0.48 |
| 3769 | rfMRI connectivity (ICA100 edge 961) | GCST90005814 | 0.48 |
| 3770 | MSRA levels | GCST90469951 | 0.48 |
| 3771 | Cholesterol in Medium VLDL | GCST90498909 | 0.48 |
| 3772 | TLR4 levels | GCST90470880 | 0.48 |
| 3773 | aseg lh intensity Lateral-Ventricle | GCST90003764 | 0.48 |
| 3774 | CA14 levels | GCST90468509 | 0.48 |
| 3775 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 0.48 |
| 3776 | Viral and other specified intestinal infections | FING00001432 | 0.47 |
| 3777 | IDP dMRI ProbtrackX ISOVF str l | GCST90004548 | 0.47 |
| 3778 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 0.47 |
| 3779 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338 | ECGU000338 | 0.47 |
| 3780 | Crohn disease (strict definition, require KELA, min 2 HDR) | FING00000366 | 0.47 |
| 3781 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 0.47 |
| 3782 | Linoleic acid levels | GCST90502310 | 0.47 |
| 3783 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 0.47 |
| 3784 | OSCAR/TNFRSF14 ratio | GCST90315588 | 0.47 |
| 3785 | MOG/RTBDN ratio | GCST90315476 | 0.47 |
| 3786 | Crohn's disease of small intestine | FING00000369 | 0.47 |
| 3787 | Free cholesterol in small VLDL | GCST90499817 | 0.47 |
| 3788 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 0.47 |
| 3789 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 0.47 |
| 3790 | Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivity | GCST90302735 | 0.46 |
| 3791 | SYT1 levels | GCST90470794 | 0.46 |
| 3792 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 0.46 |
| 3793 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498723 | 0.46 |
| 3794 | Total cholines levels | GCST90092812 | 0.46 |
| 3795 | Benign neoplasm of colon, rectum, anus and anal canal | FING00000155 | 0.46 |
| 3796 | CLEC1A levels | GCST90424231 | 0.46 |
| 3797 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | GCST90475094 | 0.46 |
| 3798 | KIR3DL1 levels | GCST90469687 | 0.46 |
| 3799 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498 | ECGU000498 | 0.46 |
| 3800 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 0.46 |
| 3801 | GZMA/GZMB ratio | GCST90315007 | 0.46 |
| 3802 | Benign neoplasm: Adrenal gland | FING00000164 | 0.46 |
| 3803 | DPEP1 levels | GCST90090302 | 0.46 |
| 3804 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 0.46 |
| 3805 | HYOU1/RARRES2 ratio | GCST90315103 | 0.46 |
| 3806 | Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivity | GCST90302673 | 0.46 |
| 3807 | HSIL lesion of the cervix uteri, vagina or vulva | FING00000625 | 0.46 |
| 3808 | PCDH1 levels | GCST90470170 | 0.46 |
| 3809 | MAP3K5/ZBTB16 ratio | GCST90315380 | 0.46 |
| 3810 | Omega-3 fatty acid levels | GCST90502425 | 0.45 |
| 3811 | Left-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302687 | 0.45 |
| 3812 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 0.45 |
| 3813 | PDGFB/TIMP3 ratio | GCST90315631 | 0.45 |
| 3814 | Blood cell traits latent factor 17 (white cell) | GCST90559259 | 0.45 |
| 3815 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320911 | 0.45 |
| 3816 | IDP dMRI TBSS ISOVF External capsule R | GCST90004509 | 0.45 |
| 3817 | DTI TBSS MD Uncinate fasciculus R | GCST90384616 | 0.45 |
| 3818 | Heart attack | GCST90475211 | 0.45 |
| 3819 | Triglycerides to total lipids in IDL percentage (UKB data field 23613) | GCST90269710 | 0.45 |
| 3820 | TANK levels | GCST90470803 | 0.45 |
| 3821 | Cholesterol to total lipids ratio in very small VLDL | GCST90093029 | 0.45 |
| 3822 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule R | GCST90004347 | 0.45 |
| 3823 | IDP dMRI ProbtrackX ISOVF ifo l | GCST90004537 | 0.45 |
| 3824 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502399 | 0.45 |
| 3825 | CLSTN2 levels | GCST90468789 | 0.45 |
| 3826 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000175 | 0.45 |
| 3827 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498000 | 0.44 |
| 3828 | PTPRB levels | GCST90470379 | 0.44 |
| 3829 | T1 FreeSurfer aseg Left-Inf-Lat-Vent | GCST90384140 | 0.44 |
| 3830 | Arm fat-free mass (left) | Impedance measures | UKBB00000047 | 0.44 |
| 3831 | Polyneuropathy in diabetes (PheCode 250.6) | GCST90475686 | 0.44 |
| 3832 | Triglycerides to total lipids in large LDL percentage (UKB data field 23618) | GCST90269715 | 0.44 |
| 3833 | Hypertension | GCST90086091 | 0.44 |
| 3834 | APOB levels | GCST90092809 | 0.44 |
| 3835 | Sleep related movement disorders (PheCode 327.7) | GCST90475827 | 0.44 |
| 3836 | Erectile dysfunction | GCST006956 | 0.44 |
| 3837 | Omega-6 fatty acids to total fatty acids percentage | GCST90499203 | 0.44 |
| 3838 | IDP dMRI TBSS MD Posterior corona radiata R | GCST90004053 | 0.44 |
| 3839 | REST UKBBICA NODEamps25 0007 | GCST90385490 | 0.44 |
| 3840 | Omega-3 fatty acids to total fatty acids percentage | GCST90502467 | 0.44 |
| 3841 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90093044 | 0.44 |
| 3842 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339 | ECGU000339 | 0.44 |
| 3843 | Right-hemisphere default mode network to thalamus white-matter structural connectivity | GCST90302844 | 0.44 |
| 3844 | MDH1 levels | GCST90469876 | 0.43 |
| 3845 | DTI autoptx FA slf l tract | GCST90385133 | 0.43 |
| 3846 | Hereditary ataxia | FING00000610 | 0.43 |
| 3847 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 0.43 |
| 3848 | CANT1/VSIR ratio | GCST90313621 | 0.43 |
| 3849 | Phospholipids to total lipids in medium HDL percentage (UKB data field 23639) | GCST90269736 | 0.43 |
| 3850 | SCG2 levels | GCST90470538 | 0.43 |
| 3851 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 0.43 |
| 3852 | Ceramide (d18:2/22:0) levels | GCST90024682 | 0.43 |
| 3853 | Cataract (PheCode 366) | GCST90043785 | 0.43 |
| 3854 | Systolic blood pressure | GCST90472782 | 0.43 |
| 3855 | CD177 levels | GCST90468603 | 0.43 |
| 3856 | Total lipid levels in large VLDL | GCST90092874 | 0.43 |
| 3857 | REG4/SPINK4 ratio | GCST90315766 | 0.43 |
| 3858 | CD58/IL10RB ratio | GCST90313850 | 0.43 |
| 3859 | CD40LG/MPIG6B ratio | GCST90313825 | 0.43 |
| 3860 | Left ventricular mass (indexed to body surface area) | GCST90435260 | 0.43 |
| 3861 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T86 | ECGU000086 | 0.43 |
| 3862 | EREG/TIMP3 ratio | GCST90314708 | 0.43 |
| 3863 | Hemoglobin A1c (HbA1c, minimum, inv-norm transformed) | GCST90475097 | 0.43 |
| 3864 | DTI autoptx L2 slf l tract | GCST90385187 | 0.43 |
| 3865 | Phospholipid levels in chylomicrons and extremely large VLDL | GCST90093048 | 0.43 |
| 3866 | AIFM1/PLXNA4 ratio | GCST90313220 | 0.43 |
| 3867 | IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosis | GCST90275789 | 0.43 |
| 3868 | Left-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302750 | 0.43 |
| 3869 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000174 | 0.43 |
| 3870 | NEFL levels | GCST90470024 | 0.42 |
| 3871 | IDP dMRI ProbtrackX L3 atr r | GCST90004303 | 0.42 |
| 3872 | BA-exvivo lh thickness BA4a | GCST90003517 | 0.42 |
| 3873 | ANXA3 levels | GCST90468318 | 0.42 |
| 3874 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 0.42 |
| 3875 | AV-block | FING00000137 | 0.42 |
| 3876 | MENT levels | GCST90469886 | 0.42 |
| 3877 | HGF/TNFSF14 ratio | GCST90315060 | 0.42 |
| 3878 | Atherosclerosis (PheCode 440) | GCST90475989 | 0.42 |
| 3879 | RGS18 levels | GCST90242617 | 0.42 |
| 3880 | rfMRI connectivity (ICA100 edge 1090) | GCST90005943 | 0.42 |
| 3881 | ANXA10 levels | GCST90468314 | 0.42 |
| 3882 | Total lipids in LDL (UKB data field 23425) | GCST90269522 | 0.42 |
| 3883 | GRAP2/PTPN6 ratio | GCST90314986 | 0.42 |
| 3884 | Atrial septal defect | FING00000128 | 0.42 |
| 3885 | DTI TBSS MD Anterior corona radiata L | GCST90384595 | 0.42 |
| 3886 | Total lipids in very small VLDL | GCST90500810 | 0.42 |
| 3887 | Concentration of large VLDL particles | GCST90092875 | 0.41 |
| 3888 | Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivity | GCST90302723 | 0.41 |
| 3889 | T1 CAT volume L LeftPutamen | GCST90384100 | 0.41 |
| 3890 | heart rate (HR, mean, inv-normal transformed) | GCST90476338 | 0.41 |
| 3891 | DTI autoptx L1 fmi tract | GCST90385150 | 0.41 |
| 3892 | IDP dMRI TBSS L2 Tapetum L | GCST90004170 | 0.41 |
| 3893 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 0.41 |
| 3894 | Chronic sputum production | GCST90269902 | 0.41 |
| 3895 | KRT8 levels | GCST90469720 | 0.41 |
| 3896 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486 | ECGA000486 | 0.41 |
| 3897 | T1 FreeSurfer BA rh BA3a exvivo thickness | GCST90385563 | 0.41 |
| 3898 | Descending aorta strain | GCST90267389 | 0.41 |
| 3899 | Mean corpuscular volume | GCST90002335 | 0.41 |
| 3900 | Phospholipids to Total Lipids in Very Large HDL percentage | GCST90500472 | 0.41 |
| 3901 | Total phospholipids in lipoprotein particles (UKB data field 23411) | GCST90269508 | 0.41 |
| 3902 | Omega-3 fatty acids to total fatty acids percentage | GCST90502088 | 0.41 |
| 3903 | NSFL1C/RILP ratio | GCST90315560 | 0.41 |
| 3904 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 0.41 |
| 3905 | Cholesterol | Blood biochemistry | UKBB00000134 | 0.41 |
| 3906 | Triglyceride levels in large VLDL | GCST90092878 | 0.41 |
| 3907 | rfMRI connectivity (ICA100 edge 1011) | GCST90005864 | 0.41 |
| 3908 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90093040 | 0.41 |
| 3909 | CALB2 levels | GCST90468527 | 0.41 |
| 3910 | CLK2 levels | GCST90240975 | 0.41 |
| 3911 | EGFR levels | GCST90469085 | 0.41 |
| 3912 | Cardiomyopathy | FING00000250 | 0.40 |
| 3913 | wg lh intensity-contrast inferiorparietal | GCST90003799 | 0.40 |
| 3914 | TNF/TNFRSF1B ratio | GCST90315942 | 0.40 |
| 3915 | Financial situation satisfaction | Mental health | UKBB00000249 | 0.40 |
| 3916 | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302676 | 0.40 |
| 3917 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259 | ECGA000259 | 0.40 |
| 3918 | Total lipids in small LDL | GCST90499656 | 0.40 |
| 3919 | GYS1/PPP1R2 ratio | GCST90315001 | 0.40 |
| 3920 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239 | ECGA000239 | 0.40 |
| 3921 | Docosahexaenoic acid levels | GCST90502259 | 0.40 |
| 3922 | Principal component-derived dietary pattern 30 | GCST90133035 | 0.40 |
| 3923 | Free cholesterol in very large VLDL | GCST90500581 | 0.40 |
| 3924 | CDH2/SSC4D ratio | GCST90313951 | 0.40 |
| 3925 | T1 CAT volume L CingulateGyrusanteriordivision | GCST90384056 | 0.40 |
| 3926 | Skin yellow/blue component | GCST90320259 | 0.40 |
| 3927 | CLEC4G/MERTK ratio | GCST90314121 | 0.40 |
| 3928 | Cholesterol in Small LDL | GCST90499555 | 0.40 |
| 3929 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T84 | ECGA000084 | 0.40 |
| 3930 | Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary Operations | UKBB00000588 | 0.40 |
| 3931 | SPARC/TJAP1 ratio | GCST90315873 | 0.40 |
| 3932 | Asthma, unspecified (mode) | FING00000120 | 0.40 |
| 3933 | CFD levels | GCST90468725 | 0.40 |
| 3934 | IL22RA2 levels | GCST90090699 | 0.40 |
| 3935 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T77 | ECGA000077 | 0.40 |
| 3936 | CSF1/SEMA3F ratio | GCST90314288 | 0.39 |
| 3937 | PHOSPHO1 levels | GCST90470227 | 0.39 |
| 3938 | PMVK/RHOC ratio | GCST90315697 | 0.39 |
| 3939 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 0.39 |
| 3940 | Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454) | GCST90269551 | 0.39 |
| 3941 | DNAJC9 levels | GCST90469018 | 0.39 |
| 3942 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39 | ECGA000039 | 0.39 |
| 3943 | Coronary artery calcification | GCST90278456 | 0.39 |
| 3944 | CTSC/PLA2G15 ratio | GCST90314311 | 0.39 |
| 3945 | wg lh intensity-contrast precentral | GCST90003815 | 0.39 |
| 3946 | CAG-776 abundance in stool | GCST90032297 | 0.39 |
| 3947 | SERPINE1/SMAD1 ratio | GCST90315833 | 0.39 |
| 3948 | ACADSB levels | GCST90468195 | 0.39 |
| 3949 | aseg lh volume Lateral-Ventricle | GCST90002616 | 0.39 |
| 3950 | Mean corpuscular hemoglobin | GCST90002323 | 0.39 |
| 3951 | Central pulse pressure | GCST90267387 | 0.39 |
| 3952 | Radial styloid tenosynovitis [de Quervain] | FING00001237 | 0.38 |
| 3953 | PCDH1/TNFRSF11A ratio | GCST90315608 | 0.38 |
| 3954 | SFRP1 levels | GCST90470610 | 0.38 |
| 3955 | Cholesteryl esters in LDL (UKB data field 23417) | GCST90269514 | 0.38 |
| 3956 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500905 | 0.38 |
| 3957 | Myocardial fractal dimension (slice 4) | GCST90000290 | 0.38 |
| 3958 | CD93/CLEC14A ratio | GCST90313921 | 0.38 |
| 3959 | Fasting blood glucose | GCST000568 | 0.38 |
| 3960 | Nasal polyps | respiratory | UKBB00000494 | 0.38 |
| 3961 | ESAM/LAMA4 ratio | GCST90314713 | 0.38 |
| 3962 | GLT25D1 levels | GCST90426421 | 0.38 |
| 3963 | Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers) | FING00000865 | 0.38 |
| 3964 | Parental longevity (combined parental attained age, Martingale residuals) | GCST006697 | 0.38 |
| 3965 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 0.38 |
| 3966 | Cholesteryl Esters in Large VLDL | GCST90498154 | 0.38 |
| 3967 | DTI TBSS L2 External capsule L | GCST90384509 | 0.38 |
| 3968 | aparc-DKTatlas lh area rostralmiddlefrontal | GCST90003259 | 0.37 |
| 3969 | INPP1 levels | GCST90469616 | 0.37 |
| 3970 | CRKL/SERPINB1 ratio | GCST90314272 | 0.37 |
| 3971 | End-diastolic bi-ventricular shape (principal component 10) | GCST90448489 | 0.37 |
| 3972 | ENO2/SCRN1 ratio | GCST90314668 | 0.37 |
| 3973 | Concentration of chylomicrons and extremely large VLDL particles | GCST90093047 | 0.37 |
| 3974 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 0.37 |
| 3975 | AXIN1/ITGB1BP2 ratio | GCST90313412 | 0.37 |
| 3976 | Asparagine levels | GCST90243758 | 0.37 |
| 3977 | DAB2/FKBP5 ratio | GCST90314363 | 0.37 |
| 3978 | Volume of right medial nucleus | GCST90475045 | 0.37 |
| 3979 | PPP2R2A levels | GCST90618122 | 0.37 |
| 3980 | ADAMTS8/FAP ratio | GCST90313172 | 0.37 |
| 3981 | NUDT2 levels | GCST90470106 | 0.37 |
| 3982 | DTI TBSS L3 Sagittal stratum R | GCST90384554 | 0.37 |
| 3983 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 0.37 |
| 3984 | PDCD6 levels | GCST90470183 | 0.37 |
| 3985 | Phosphatidylcholine-2O_32:0_[M+H]1+ levels | GCST90060244 | 0.37 |
| 3986 | Phospholipids to total lipids in small VLDL percentage (UKB data field 23599) | GCST90269696 | 0.37 |
| 3987 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90093042 | 0.37 |
| 3988 | Osteoporosis (PheCode 743.1) | GCST90476384 | 0.37 |
| 3989 | Pre-eclampsia or eclampsia | FING00001201 | 0.37 |
| 3990 | Flavonifractor sp002159265 abundance in stool | GCST90032400 | 0.37 |
| 3991 | Diseases of oesophagus, stomach and duodenum | FING00000428 | 0.37 |
| 3992 | Triglycerides to total lipids in small HDL percentage (UKB data field 23648) | GCST90269745 | 0.36 |
| 3993 | Omega-3 fatty acid levels | GCST90502061 | 0.36 |
| 3994 | aparc-a2009s lh area S-postcentral | GCST90003363 | 0.36 |
| 3995 | Heart valve disorders (PheCode 395) | GCST90475913 | 0.36 |
| 3996 | IDP dMRI ProbtrackX ISOVF slf r | GCST90004547 | 0.36 |
| 3997 | CDKN1A/PLA2G4A ratio | GCST90313974 | 0.36 |
| 3998 | T1 CAT volume R RightAccumbens | GCST90384109 | 0.36 |
| 3999 | Coronary heart disease | GCST000998 | 0.36 |
| 4000 | RILP levels | GCST90470471 | 0.36 |